Six months after receiving Emergency Use Authorization from the U.S. Food and Drug Administration for Covid-19 vaccines, Pfizer/BioNTech and Moderna are seeking full approval...
Children two to five years of age can benefit from lumacaftor/ivacaftor treatment for up to 120 weeks Credit: Children’s Hospital Colorado Children ages two to five...
Which penny stocks should you know about in 2021? Take a look at these 3 The post 3 Penny Stocks That Investors Need to Watch In...
Johnson & Johnson Vision (JNJ) has received approval in the US for TECNIS Synergy and TECNIS Synergy Toric II IOLs. In Canada, it received approval for...
Futures Flat As Traders Look For Buying Catalyst For the fourth morning in a row, futures are barely changed - a stark reversal to the previous...
On Tuesday, pharma giant Pfizer (PFE) reported a standout quarter. The results contrasted those of most other large-cap pharma companies. Surprisingly, the strong showing did not seem...
Amryt inked an all-stock acquisition deal with Chiasma. The combined company will focus on rare and orphan diseases with three marketed products and a strong development pipeline.
How do medical devices get approved? Learn about the FDA's intricate process for classifying and regulating these products in the US. The post How Do Medical...
After an indifferent period Novo Nordisk has kicked off 2021 on the front foot, raising its financial forecast The post Novo Nordisk ups forecasts after Q1...
Novamind (NM.C) announced they are opening four new Cedar Psychiatric clinics, doubling the number of clinics in there network. The expanded capacity for the new clinics...
President Joe Biden on May 4 announced a goal to vaccinate 70 percent of U.S. adults with at least one Covid-19 shot by the July 4...
Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it The post Pfizer says COVID-19 jab could rake...
CNBC Exclusive: CNBC Transcript: Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla Speaks with CNBC’s “The Exchange” Today Q1 2021 hedge fund letters, conferences and more...
Best penny stocks to watch in 2021? Here are 3 for your long term watchlist The post Trending Penny Stocks To Watch in 2021? Take a...
Another day, another Tetra Bio-Pharma (TBP.T) news release. A day after they were granted a Drug Establishment Licence by Health Canada for their REDUVO soft gel...
Pfizer reported first-quarter 2021 revenue of $14.6 billion, an impressive 42 percent operational growth. The company's Covid-19 vaccine revenue accounted for $3.5 billion of the total.
The combined technologies could reduce labor and time required for COVID-19 diagnostic testing 10-fold, and facilitate future diagnostic testing of other respiratory diseases Credit: Wyss Institute...
The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc. and BioNTech SE's Covid-19 vaccine for adolescents aged between 12 and 15 years by...
Now more than one year since the onset of COVID-19, empty grocery store shelves and panicked shoppers have become the sine qua non of the pandemic’s...
As the ongoing COVID-19 pandemic has taught us, it is essential for global biopharmaceutical manufacturers to manage their end-to-end supply chains, taking into consideration the supply...
Adeno-associated virus (AAV) vectors are the leading vectors for gene delivery. AAV vectors pose challenges including costly manufacture, high percentages of empty capsids, and safety issues...
CloseCloseCloseHealthcare has been lagging the market, but that is now changing.As biotechs consolidate, other healthcare industry groups are powering the sector to a breakout.Medical Devices and...
Welcome to TDR’s review of the Top 5 Psychedelic developments of the past week. Aside from presenting a synopsis of events, we provide market commentary to...
The submission of U.S. approval for AstraZeneca’s Covid-19 vaccine was pushed back to mid-May, with the company citing the massive dataset as the cause.
In a roundup review of scientific studies recently published, a study out of RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance...
Bristol Myers Squibb (BMY) posted disappointing results in the first quarter as the pharmaceutical company’s revenues rose 3% year-on-year to $11.1 billion, but fell short of...
Tech penny stocks are back in focus; check these 3 out
Ken Frazier’s final appearance on Merck & Co’s financial results call as chief executive was a muted affair, as The post Merck looks at M&A deals as...
Futures Slide On Last Day Of April Despite Blowout Earnings And Econ Data "As good as it gets." U.S. index futures slumped on the final trading...
The developments are coming in thick and fast at Sorrento Therapeutics (SRNE). Recent times have seen a flurry of announcements regrading the company’s bulging pipeline. Earlier...